Oxygen Therapy Market

consolidation of this equipment in the extensive variety of uses as the first line of treatment.
On the basis of application, it is segmented into Chronic Obstructive Pulmonary Disease,
Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Cystic Fibrosis,
Pneumonia. Chronic obstructive pulmonary disease holds the largest share of the
application segment and it is anticipated to grow lucratively at a CAGR of over 10.5% over
the next five years. This is due to increasing popularity of supplemental administration in
conjunction with first line treatments available for COPD. Moreover, this treatment includes
faster response rates, reliability and portability, and above all improves chances of survival.
On the basis of end use it is segmented into Home Healthcare and Hospitals. Home health
care dominates the end-use segment, owing to the rise in elderly population coupled with
increasing number of patients with low mobility and long-term care requirement in
conditions such as Alzheimer’s disease.
On the basis of geography, the global market is analyzed under various regions namely
North America, Europe, Asia-Pacific and Rest of the World. In 2016, the major share of
oxygen therapy market’s revenue was held by North America at staggering 40.0%. High
R&D investments and an increase in the number of product endorsements have been the
key growth drivers responsible for the North America’s largest share of the market. It is
followed by Europe in terms of revenue share owing to the presence of favorable
government initiatives for improving respiratory care, such as European Committee for
Hyperbaric Medicine (ECHM), involved in promoting awareness pertaining to the treatment.
The Asia-Pacific region is expected to offer a lucrative market in the future due to the
increasing elderly population who require home-based oxygen therapy. Furthermore, a rise
in healthcare expenditure in emerging economies such as China and India will further fuel
the market.
Respironics Inc. (a Philips company), Teleflex Incorporated, AirSep Corporation, DeVilbiss
Healthcare, ResMed Inc, Fisher & Paykel Healthcare Limited, Invacare Corporation are
some of the leading companies in the global oxygen therapy devices market.
About Us:
Market Data Forecast is a firm working in the area of market research and business
intelligence. With rich experience in research across various business domains, we
cater to the needs of both individual and corporate clients. Our analyst team comprises
expert professionals in market research, who with their collective knowledge and
sksillset dedicatedly serve clients from various industries and regions.